Honey in Chronic Immune Thrombocytopenia

计划入组 30 人 · 首次发布于 2011 年 11 月 1 日

Daclizumab to Treat Chronic Immune Thrombocytopenia

计划入组 24 人 · 首次发布于 2002 年 11 月 13 日

Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

计划入组 35 人 · 首次发布于 2012 年 8 月 24 日

Fostamatinib(Tavalisse, Tavlesse)

C₂₃H₂₆FN₆O₉P · Rx

Romiplostim(Nplate)

iPSC-derived allogenic cell therapy (immune thrombocytopenia)

Kineta Chronic Pain LLC

United States

AC Immune

Switzerland

Immune Biosolutions Inc

Canada

CASI Pharmaceuticals Initiates Phase 1/2 Trial of CID-103 for Immune Thrombocytopenia

FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation

Sanofi's Wayrilz Becomes First BTK Inhibitor Approved for Immune Thrombocytopenia Treatment